1-5 of 5
Bruno Bockorny
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial

Francesca Sarno, Jair Tenorio, Sofia Perea, Laura Medina, Roberto Pazo-Cid, Ignacio Juez, Rocío Garcia-Carbonero, Jaime Feliu, Carmen Guillen-Ponce, Pedro P. Lopez-Casas, Carmen Guerra, Yolanda Duran, José Francisco López-Acosta, Carolina Alonso, Estrella Esquivel, Ana Dopazo, Dipikaa Akshinthala, Senthil K. Muthuswamy, Pablo Lapunzina, Bruno Bockorny, Manuel Hidalgo
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (2): 278–287.
https://doi.org/10.1158/1078-0432.CCR-23-4026
Published: 17 January 2025
View article titled, A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial
Open the PDF for A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial in another window
Includes: Supplementary data
Journal Articles

Facts and Hopes in Immunotherapy of Pancreatic Cancer

Bruno Bockorny, Joseph E. Grossman, Manuel Hidalgo
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (21): 4606–4617.
https://doi.org/10.1158/1078-0432.CCR-21-3452
Published: 01 November 2022
View article titled, Facts and Hopes in Immunotherapy of Pancreatic Cancer
Open the PDF for Facts and Hopes in Immunotherapy of Pancreatic Cancer in another window
Journal Articles

Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer

Joseph E. Grossman, Lakshmi Muthuswamy, Ling Huang, Dipikaa Akshinthala, Sofia Perea, Raul S. Gonzalez, Leo L. Tsai, Jonah Cohen, Bruno Bockorny, Andrea J. Bullock, Benjamin Schlechter, Mary Linton B. Peters, Catherine Conahan, Supraja Narasimhan, Christine Lim, Roger B. Davis, Robert Besaw, Mandeep S. Sawhney, Douglas Pleskow, Tyler M. Berzin, Martin Smith, Tara S. Kent, Mark Callery, Senthil K. Muthuswamy, Manuel Hidalgo
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 708–718.
https://doi.org/10.1158/1078-0432.CCR-20-4116
Published: 15 February 2022
View article titled, Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer
Open the PDF for Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial

Bruno Bockorny, Teresa Macarulla, Valerya Semenisty, Erkut Borazanci, Jaime Feliu, Mariano Ponz-Sarvise, David Gutierrez Abad, Paul Oberstein, Angela Alistar, Andres Muñoz, Ravit Geva, Carmen Guillén-Ponce, Mercedes Salgado Fernandez, Amnon Peled, Marya Chaney, Irit Gliko-Kabir, Liron Shemesh-Darvish, Debby Ickowicz, Ella Sorani, Shaul Kadosh, Abi Vainstein-Haras, Manuel Hidalgo
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (18): 5020–5027.
https://doi.org/10.1158/1078-0432.CCR-21-0929
Published: 15 September 2021
View article titled, Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial
Open the PDF for Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial in another window
Includes: Supplementary data
Journal Articles

OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models

Myriam Fabre, Cristina Ferrer, Saioa Domínguez-Hormaetxe, Bruno Bockorny, Laura Murias, Oliver Seifert, Stephan A. Eisler, Roland E. Kontermann, Klaus Pfizenmaier, So Young Lee, María dM. Vivanco, Pedro P. López-Casas, Sofia Perea, Muhammad Abbas, Wolfgang Richter, Laureano Simon, Manuel Hidalgo
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13): 3420–3430.
https://doi.org/10.1158/1078-0432.CCR-19-2238
Published: 01 July 2020
View article titled, OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models
Open the PDF for OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models in another window
Includes: Supplementary data